infertility. female infertility associated with male factor
Conditions
Interventions
Intervention 1: The day of embryo transfer, 1500 IU hcG (human chorionic gonadotropin) will be injected intermuscular in one group. Intervention 2: The day of embryo transfer, 500 IU hcG (human chorio
Treatment - Drugs
The day of embryo transfer, 1500 IU hcG (human chorionic gonadotropin) will be injected intermuscular in one group
The day of embryo transfer, 500 IU hcG (human chorionic gonadotropin) will be injected 7 minutes before embryo transfer
Sponsors
Vice Chancellor for Research , Tehran University of Medical Sceinces
Eligibility
Sex/Gender
Female
Age
16 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: couples undergoing ART with their own gametes; good and high responder women; women age less than 40, FSH level less than 10 mIU/ml on third day of mense, AMH more than 1.1 ng/ml; couples having at least one embryo available for transfer. Exclusion criteria: couples undergoing ART with donation gamate; azospermia; poor responder women: women age more than 40, FSH level more than 10 mIU/ml on third day of mense, AMH less than 1.1 ng/ml and less than 4 f0llicles in previous ART cycle.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: eight weeks after intervention. Method of measurement: vaginal sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Implantation rate. Timepoint: Ten weeks after intervention. Method of measurement: vaginal sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeedeh Gharahjeh
Tehran University of Medical Sciences
Outcome results
None listed